How to provide information on histological severity diagnosis or prognosis measurement of non-alcoholic fatty liver disease

摘要

The present invention relates to a method for providing information on histological diagnosis or prognosis of non-alcoholic fatty liver disease when the content of sphingomyelin is 1.3 times or more that of a normal control group. Since it can be determined that the risk associated with the severity of the disease has increased, this can be effectively used for severity diagnosis or prognosis measurement. [Selection diagram] Fig. 4